Lascifloxacin 75 mg 50 tablets
Lascifloxacin: A Next-Generation Fluoroquinolone for Systemic Antibacterial Therapy
Within the respiratory fluoroquinolone group, a newer contender has emerged: Lascifloxacin. This is a broad-spectrum antimicrobial agent, presented in 75 mg oral tablets with a pack size of 50 — designed to cover an extended therapeutic cycle. The compound is engineered for the targeted eradication of bacterial pathogens that exhibit resistance to many other antibiotic classes. Let’s examine its clinical profile in depth.
Lascifloxacin belongs to the fluoroquinolone class — synthetic antibacterial agents whose mechanism is based on the inhibition of two vital bacterial enzymes: DNA-gyrase and topoisomerase IV. By blocking these molecular targets, the drug disrupts DNA replication and repair processes within the microorganism, leading to its rapid death (a bactericidal effect).
The susceptibility spectrum covers:
This tailored profile positions Lascifloxacin as a versatile tool for managing infections across varied anatomical sites.
Key indications fall into three primary clinical domains:
A Crucial Absorption Nuance: Lascifloxacin forms insoluble complexes with polyvalent metal ions, which drastically curtails its bioavailability. Therefore, it is absolutely essential to separate the intake of this drug from:
A strict interval of at least 2 to 4 hours must be maintained between Lascifloxacin and such products.
Absolute restrictions govern Lascifloxacin use:
Like all antibiotics, Lascifloxacin has the potential to trigger undesired effects. Among the most commonly registered:
Special—though rare—class-specific conditions associated with fluoroquinolones include tendinitis (inflammation of tendons) and the risk of tendon rupture, particularly in elderly patients and those concurrently taking glucocorticosteroids.
Emergency Signal: Should any anaphylaxis symptoms emerge — breathing difficulty, swelling of the face, lips, or throat, a sharp drop in blood pressure — immediate emergency medical assistance must be sought.
The product must be kept inside its original cardboard packaging, in a dry environment shielded from direct sunlight. The temperature regime is standard room temperature (15–25 °C / 59–77 °F). Ensure the storage location remains inaccessible to children.
Final Counsel: Lascifloxacin is a potent, prescription-only antibiotic. Its uncontrolled usage is not only hazardous to personal health but also fuels the global public-health crisis of antimicrobial resistance. Only a qualified physician can competently justify its prescription, weighing the clinical presentation, bacterial culture data, and the individual physiological profile of the patient.

